Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1321

1.

Correlation of extent of ALK FISH positivity and crizotinib efficacy in three prospective studies of ALK-positive patients with non-small cell lung cancer.

Soria JC, Ho SN, Varella-Garcia M, Iafrate AJ, Solomon BJ, Shaw AT, Blackhall F, Mok TS, Wu YL, Pestova K, Wilner KD, Polli A, Paolini J, Lanzalone S, Green S, Camidge DR.

Ann Oncol. 2018 Jul 13. doi: 10.1093/annonc/mdy242. [Epub ahead of print]

PMID:
30010763
2.

[A case report on occupational acute nbutyllithium poisoning].

Wang SS, Li M, Wu YL.

Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi. 2018 Mar 20;36(3):223. doi: 10.3760/cma.j.issn.1001-9391.2018.03.019. Chinese. No abstract available.

PMID:
29996231
3.

Targeted and Sustained Corelease of Chemotherapeutics and Gene by Injectable Supramolecular Hydrogel for Drug-Resistant Cancer Therapy.

Liu X, Li Z, Loh XJ, Chen K, Li Z, Wu YL.

Macromol Rapid Commun. 2018 Jul 10:e1800117. doi: 10.1002/marc.201800117. [Epub ahead of print]

PMID:
29992700
4.

Two New Chromone Glycosides from Roots of Saposhnikovia divaricata.

Ma SY, Shi LG, Gu ZB, Wu YL, Wei LB, Wei QQ, Gao XL, Liao N.

Chem Biodivers. 2018 Jul 10. doi: 10.1002/cbdv.201800253. [Epub ahead of print]

PMID:
29987893
5.

Effects of napping on cognitive function modulation in elderly adults with a morning chronotype: A nationwide survey.

Fang SC, Huang CJ, Wu YL, Wu PY, Tsai PS.

J Sleep Res. 2018 Jul 9:e12724. doi: 10.1111/jsr.12724. [Epub ahead of print]

PMID:
29984443
6.

Heterogeneous responses and resistant mechanisms to crizotinib in ALK-positive advanced non-small cell lung cancer.

Kang J, Chen HJ, Zhang XC, Su J, Zhou Q, Tu HY, Wang Z, Wang BC, Zhong WZ, Yang XN, Chen ZH, Ding Y, Wu X, Wang M, Fu JG, Yang Z, Zhang X, Shao YW, Wu YL, Yang JJ.

Thorac Cancer. 2018 Jul 6. doi: 10.1111/1759-7714.12791. [Epub ahead of print]

PMID:
29978950
7.

Green dialysate and gallbladder perforation in a peritoneal dialysis patients: a case report and literature review.

Wu YL, Lin YS, Hsueh TY, Lo WC, Peng KC, Kao MJ.

BMC Nephrol. 2018 Jul 4;19(1):165. doi: 10.1186/s12882-018-0974-6.

8.

[Effect of sandblasting on bending strength and subcritical crack growth of the dental zirconia ceramics].

Gong X, Zhao XY, Zhang CB, Li SB, Wu YL, Wu B.

Zhonghua Kou Qiang Yi Xue Za Zhi. 2017 Jul 9;52(7):439-442. doi: 10.3760/cma.j.issn.1002-0098.2017.07.009. Chinese.

PMID:
29972909
9.

Results of PROFILE 1029, a Phase III Comparison of First-Line Crizotinib versus Chemotherapy in East Asian Patients with ALK-Positive Advanced Non-Small Cell Lung Cancer.

Wu YL, Lu S, Lu Y, Zhou J, Shi YK, Sriuranpong V, Ho JCM, Ong CK, Tsai CM, Chung CH, Wilner KD, Tang Y, Masters ET, Selaru P, Mok TS.

J Thorac Oncol. 2018 Jun 29. pii: S1556-0864(18)30721-4. doi: 10.1016/j.jtho.2018.06.012. [Epub ahead of print]

PMID:
29966800
10.

Immunotherapy in the Asiatic population: any differences from Caucasian population?

Peng L, Wu YL.

J Thorac Dis. 2018 May;10(Suppl 13):S1482-S1493. doi: 10.21037/jtd.2018.05.106. Review.

11.

Satisfaction with care after reducing opioids for chronic pain.

Sharp AL, Shen E, Wu YL, Wong A, Menchine M, Kanter MH, Gould MK.

Am J Manag Care. 2018 Jun 1;24(6):e196-e199.

12.

Regulation of the regulator of G protein signaling 2 expression and cellular localization by PKA and PKC pathways in mouse granulosa cells.

Yeh HY, Sun D, Peng YC, Wu YL.

Biochem Biophys Res Commun. 2018 Jun 20. pii: S0006-291X(18)31413-X. doi: 10.1016/j.bbrc.2018.06.101. [Epub ahead of print]

PMID:
29932914
13.

Ginsenoside 25-OCH3-PPD Promotes Activity of LXRs To Ameliorate P2X7R-Mediated NLRP3 Inflammasome in the Development of Hepatic Fibrosis.

Han X, Song J, Lian LH, Yao YL, Shao DY, Fan Y, Hou LS, Wang G, Zheng S, Wu YL, Nan JX.

J Agric Food Chem. 2018 Jul 11;66(27):7023-7035. doi: 10.1021/acs.jafc.8b01982. Epub 2018 Jul 2.

PMID:
29929367
14.

Combinatorial Nano-Bio Interfaces.

Cai P, Zhang X, Wang M, Wu YL, Chen X.

ACS Nano. 2018 Jun 8. doi: 10.1021/acsnano.8b03285. [Epub ahead of print]

PMID:
29883094
15.

Biomechano-Interactive Materials and Interfaces.

Cai P, Hu B, Leow WR, Wang X, Loh XJ, Wu YL, Chen X.

Adv Mater. 2018 Jun 7:e1800572. doi: 10.1002/adma.201800572. [Epub ahead of print] Review.

PMID:
29882230
16.

Recent Progress in Macromolecule-Anchored Hybrid Gold Nanomaterials for Biomedical Applications.

Luo Z, Xu Y, Ye E, Li Z, Wu YL.

Macromol Rapid Commun. 2018 Jun 4:e1800029. doi: 10.1002/marc.201800029. [Epub ahead of print] Review.

PMID:
29869424
17.

Improvement in Overall Survival in a Randomized Study That Compared Dacomitinib With Gefitinib in Patients With Advanced Non-Small-Cell Lung Cancer and EGFR-Activating Mutations.

Mok TS, Cheng Y, Zhou X, Lee KH, Nakagawa K, Niho S, Lee M, Linke R, Rosell R, Corral J, Migliorino MR, Pluzanski A, Sbar EI, Wang T, White JL, Wu YL.

J Clin Oncol. 2018 Jun 4:JCO2018787994. doi: 10.1200/JCO.2018.78.7994. [Epub ahead of print]

PMID:
29864379
18.

Glycogen-nucleic acid constructs for gene silencing in multicellular tumor spheroids.

Wojnilowicz M, Besford QA, Wu YL, Loh XJ, Braunger JA, Glab A, Cortez-Jugo C, Caruso F, Cavalieri F.

Biomaterials. 2018 Sep;176:34-49. doi: 10.1016/j.biomaterials.2018.05.024. Epub 2018 May 20.

PMID:
29857273
19.

EGFR L792H and G796R: Two Novel Mutations Mediating Resistance to the Third-Generation Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Osimertinib.

Zhang Q, Zhang XC, Yang JJ, Yang ZF, Bai Y, Su J, Wang Z, Zhang Z, Shao Y, Zhou Q, Kang J, Ke EE, Zhang YC, Dong ZY, Chen ZH, Tu HY, Zhong WZ, Yang XN, Wu YL.

J Thorac Oncol. 2018 May 29. pii: S1556-0864(18)30637-3. doi: 10.1016/j.jtho.2018.05.024. [Epub ahead of print]

PMID:
29857056
20.

VHL loss predicts response to Aurora kinase A inhibitor in renal cell carcinoma cells.

Ding XF, Zhou J, Chen G, Wu YL.

Mol Med Rep. 2018 Jul;18(1):1206-1210. doi: 10.3892/mmr.2018.9038. Epub 2018 May 17.

PMID:
29845253
21.

{Nb288 O768 (OH)48 (CO3 )12 }: A Macromolecular Polyoxometalate with Close to 300 Niobium Atoms.

Wu YL, Li XX, Qi YJ, Yu H, Jin L, Zheng ST.

Angew Chem Int Ed Engl. 2018 Jul 9;57(28):8572-8576. doi: 10.1002/anie.201804088. Epub 2018 Jun 14.

PMID:
29809317
22.

Targeting of PP2Cδ By a Small Molecule C23 Inhibits High Glucose-Induced Breast Cancer Progression In Vivo.

Wu K, Yu X, Huang Z, Zhu D, Yi X, Wu YL, Hao Q, Kemp KT 2nd, Elshimali Y, Iyer R, Nguyen KT, Zheng S, Chen G, Chen QH, Wang G, Vadgama JV, Wu Y.

Antioxid Redox Signal. 2018 Jul 13. doi: 10.1089/ars.2017.7486. [Epub ahead of print]

PMID:
29808718
23.

Cyclodextrin-Based Star-Like Amphiphilic Cationic Polymer as a Potential Pharmaceutical Carrier in Macrophages.

Cheng H, Fan X, Wu C, Wang X, Wang LJ, Loh XJ, Li Z, Wu YL.

Macromol Rapid Commun. 2018 May 28:e1800207. doi: 10.1002/marc.201800207. [Epub ahead of print]

PMID:
29806229
24.

ADAURA: Phase III, Double-blind, Randomized Study of Osimertinib Versus Placebo in EGFR Mutation-positive Early-stage NSCLC After Complete Surgical Resection.

Wu YL, Herbst RS, Mann H, Rukazenkov Y, Marotti M, Tsuboi M.

Clin Lung Cancer. 2018 Jul;19(4):e533-e536. doi: 10.1016/j.cllc.2018.04.004. Epub 2018 May 1.

25.

Toward innovative combinational immunotherapy: A systems biology perspective.

Li XT, Yang JJ, Wu YL, Hou J.

Cancer Treat Rev. 2018 May 8;68:1-8. doi: 10.1016/j.ctrv.2018.05.003. [Epub ahead of print] Review.

PMID:
29775845
26.

Final Overall Survival Analysis From a Study Comparing First-Line Crizotinib Versus Chemotherapy in ALK-Mutation-Positive Non-Small-Cell Lung Cancer.

Solomon BJ, Kim DW, Wu YL, Nakagawa K, Mekhail T, Felip E, Cappuzzo F, Paolini J, Usari T, Tang Y, Wilner KD, Blackhall F, Mok TS.

J Clin Oncol. 2018 May 16:JCO2017774794. doi: 10.1200/JCO.2017.77.4794. [Epub ahead of print]

PMID:
29768118
27.

Rivaroxaban does not influence hemorrhagic transformation in a diabetes ischemic stroke and endovascular thrombectomy model.

Liu FD, Zhao R, Feng XY, Shi YH, Wu YL, Shen XL, Li GF, Liu YS, Zhao Y, He XW, Yin JW, Zhuang MT, Zhao BQ, Liu JR.

Sci Rep. 2018 May 9;8(1):7408. doi: 10.1038/s41598-018-25820-y.

28.

[Effects of obesity on global genome DNA methylation and gene imprinting in mouse spermatozoa].

Zhu JL, Wu YL, Tang WH, Tian Y, Ge SQ, Liu P, Qiao J.

Zhonghua Nan Ke Xue. 2017 Jun;23(6):488-496. Chinese.

PMID:
29722939
29.

Relationship between body mass index and renal function deterioration among the Taiwanese chronic kidney disease population.

Chang TJ, Zheng CM, Wu MY, Chen TT, Wu YC, Wu YL, Lin HT, Zheng JQ, Chu NF, Lin YM, Su SL, Lu KC, Chen JS, Sung FC, Lee CT, Yang Y, Hwang SJ, Wang MC, Hsu YH, Chiou HY, Kao S, Lin YF.

Sci Rep. 2018 May 2;8(1):6908. doi: 10.1038/s41598-018-24757-6.

30.

Amelioration of Alcoholic Liver Steatosis by Dihydroquercetin through the Modulation of AMPK-Dependent Lipogenesis Mediated by P2X7R-NLRP3-Inflammasome Activation.

Zhang Y, Jin Q, Li X, Jiang M, Cui BW, Xia KL, Wu YL, Lian LH, Nan JX.

J Agric Food Chem. 2018 May 16;66(19):4862-4871. doi: 10.1021/acs.jafc.8b00944. Epub 2018 May 4.

PMID:
29706079
31.

Supramolecular hydrogels for antimicrobial therapy.

Hu B, Owh C, Chee PL, Leow WR, Liu X, Wu YL, Guo P, Loh XJ, Chen X.

Chem Soc Rev. 2018 Apr 26. doi: 10.1039/c8cs00128f. [Epub ahead of print]

PMID:
29697128
32.

Histone deacetylase inhibitor treatment restores memory-related gene expression and learning ability in neonicotinoid-treated Apis mellifera.

Hu YT, Tang CK, Wu CP, Wu PC, Yang EC, Tai CC, Wu YL.

Insect Mol Biol. 2018 Apr 25. doi: 10.1111/imb.12390. [Epub ahead of print]

PMID:
29693770
33.

[Guidenline for diagnosis and treatment of Alk and Ros1 positive non-small cell lung cancer in China].

Zhang XC, Lu S, Zhang L, Liao ML, Wang CL, Cheng Y, Li GD, Mok SJ, Huang C, Liu XQ, Wang J, Wang MZ, Zhang YP, Zhou JY, Zhou XJ, Zhou XY, Lin DM, Yang JJ, Song Y, Hu CP, Wang K, He Y, Li H, Zhong WZ, Wu YL; Tumor Marker Committee of Chinese Society of Clinical Oncology.

Zhonghua Bing Li Xue Za Zhi. 2018 Apr 8;47(4):241-247. doi: 10.3760/cma.j.issn.0529-5807.2018.04.003. Chinese. No abstract available.

PMID:
29690661
34.

Autoantibodies against islet cell antigens in children with type 1 diabetes mellitus.

Cheng BW, Lo FS, Wang AM, Hung CM, Huang CY, Ting WH, Yang MO, Lin CH, Chen CC, Lin CL, Wu YL, Lee YJ.

Oncotarget. 2018 Feb 19;9(23):16275-16283. doi: 10.18632/oncotarget.24527. eCollection 2018 Mar 27.

35.

Afatinib as First-line Treatment of Older Patients With EGFR Mutation-Positive Non-Small-Cell Lung Cancer: Subgroup Analyses of the LUX-Lung 3, LUX-Lung 6, and LUX-Lung 7 Trials.

Wu YL, Sequist LV, Tan EH, Geater SL, Orlov S, Zhang L, Lee KH, Tsai CM, Kato T, Barrios CH, Schuler M, Hirsh V, Yamamoto N, O'Byrne K, Boyer M, Mok T, Peil B, Märten A, Chih-Hsin Yang J, Paz-Ares L, Park K.

Clin Lung Cancer. 2018 Jul;19(4):e465-e479. doi: 10.1016/j.cllc.2018.03.009. Epub 2018 Mar 17.

36.

Phase II Study of Crizotinib in East Asian Patients With ROS1-Positive Advanced Non-Small-Cell Lung Cancer.

Wu YL, Yang JC, Kim DW, Lu S, Zhou J, Seto T, Yang JJ, Yamamoto N, Ahn MJ, Takahashi T, Yamanaka T, Kemner A, Roychowdhury D, Paolini J, Usari T, Wilner KD, Goto K.

J Clin Oncol. 2018 May 10;36(14):1405-1411. doi: 10.1200/JCO.2017.75.5587. Epub 2018 Mar 29.

PMID:
29596029
37.

The Value of Early Depth of Response in Predicting Long-Term Outcome in EGFR-Mutant Lung Cancer.

Lee CK, Lord S, Marschner I, Wu YL, Sequist L, Rosell R, Fukuoka M, Mitsudomi T, Asher R, Davies L, Gebski V, Gralla R, Mok T, Chih-Hsin Yang J.

J Thorac Oncol. 2018 Jun;13(6):792-800. doi: 10.1016/j.jtho.2018.03.010. Epub 2018 Mar 23.

PMID:
29580950
38.

Reparative Effects of Astaxanthin-Hyaluronan Nanoaggregates against Retrorsine-CCl₄-Induced Liver Fibrosis and Necrosis.

Wu YJ, Wu YC, Chen IF, Wu YL, Chuang CW, Huang HH, Kuo SM.

Molecules. 2018 Mar 22;23(4). pii: E726. doi: 10.3390/molecules23040726.

39.

Cognitive Impairment in Fibromyalgia: A Meta-Analysis of Case-Control Studies.

Wu YL, Huang CJ, Fang SC, Ko LH, Tsai PS.

Psychosom Med. 2018 Jun;80(5):432-438. doi: 10.1097/PSY.0000000000000575.

PMID:
29528888
40.

Influence of fetal Leydig cells on the development of adult Leydig cell population in rats.

Su DM, Feng Y, Wang L, Wu YL, Ge RS, Ma X.

J Reprod Dev. 2018 Jun 22;64(3):223-231. doi: 10.1262/jrd.2017-102. Epub 2018 Mar 6.

41.

Therapeutic effects of antimicrobial peptide on malignant ascites in a mouse model.

Xia LJ, Wu YL, Ma J, Zhang FC.

Mol Med Rep. 2018 May;17(5):6245-6252. doi: 10.3892/mmr.2018.8691. Epub 2018 Mar 7.

42.

Rhynchophylline suppresses soluble Aβ1-42-induced impairment of spatial cognition function via inhibiting excessive activation of extrasynaptic NR2B-containing NMDA receptors.

Yang Y, Ji WG, Zhu ZR, Wu YL, Zhang ZY, Qu SC.

Neuropharmacology. 2018 Jun;135:100-112. doi: 10.1016/j.neuropharm.2018.03.007. Epub 2018 Mar 3.

PMID:
29510187
43.

Adjuvant therapy for resected EGFR-mutant non-small-cell lung cancer - Authors' reply.

Wu YL, Zhong WZ.

Lancet Oncol. 2018 Mar;19(3):e127. doi: 10.1016/S1470-2045(18)30133-5. No abstract available.

PMID:
29508752
44.

Thermogelling 3D Systems towards Stem Cell-Based Tissue Regeneration Therapies.

Wang X, Young DJ, Wu YL, Loh XJ.

Molecules. 2018 Mar 2;23(3). pii: E553. doi: 10.3390/molecules23030553.

45.

Tongxinluo Improves Apolipoprotein E-Deficient Mouse Heart Function.

Yuan GQ, Gao S, Geng YJ, Tang YP, Zheng MJ, Shelat HS, Collins S, Wu HJ, Wu YL.

Chin Med J (Engl). 2018 Mar 5;131(5):544-552. doi: 10.4103/0366-6999.226063.

46.

The impact of EGFR mutations on the incidence and survival of stages I to III NSCLC patients with subsequent brain metastasis.

Chang WY, Wu YL, Su PL, Yang SC, Lin CC, Su WC.

PLoS One. 2018 Feb 15;13(2):e0192161. doi: 10.1371/journal.pone.0192161. eCollection 2018.

47.

A Series of Banana-Shaped 3d-4f Heterometallic Cluster Substituted Polyoxometalates: Syntheses, Crystal Structures, and Magnetic Properties.

Gu YN, Chen Y, Wu YL, Zheng ST, Li XX.

Inorg Chem. 2018 Mar 5;57(5):2472-2479. doi: 10.1021/acs.inorgchem.7b02728. Epub 2018 Feb 14.

PMID:
29442500
48.

Transgelin-2 as a therapeutic target for asthmatic pulmonary resistance.

Yin LM, Xu YD, Peng LL, Duan TT, Liu JY, Xu Z, Wang WQ, Guan N, Han XJ, Li HY, Pang Y, Wang Y, Chen Z, Zhu W, Deng L, Wu YL, Ge GB, Huang S, Ulloa L, Yang YQ.

Sci Transl Med. 2018 Feb 7;10(427). pii: eaam8604. doi: 10.1126/scitranslmed.aam8604.

PMID:
29437149
49.

MiR-539 inhibits proliferation and migration of triple-negative breast cancer cells by down-regulating LAMA4 expression.

Yang ZX, Zhang B, Wei J, Jiang GQ, Wu YL, Leng BJ, Xing CG.

Cancer Cell Int. 2018 Jan 30;18:16. doi: 10.1186/s12935-018-0512-4. eCollection 2018.

50.

[Clinicopathologic features and prognosis of inflammatory pseudotumor-like follicular dendritic cell sarcomas in liver and spleen: an analysis of seven cases].

Wu YL, Wu F, Yang L, Sun H, Yan XC, Duan GJ.

Zhonghua Bing Li Xue Za Zhi. 2018 Feb 8;47(2):114-118. doi: 10.3760/cma.j.issn.0529-5807.2018.02.007. Chinese.

PMID:
29429163

Supplemental Content

Support Center